ITGA11 regulates key immunoinflammatory pathways, extracellular matrix interactions, and cellular biological processes, and may serve as a promising biomarker for the early detection and prevention of complications associated with IAs and AAAs. Here, ITGA11 is linked to achalasia-alacrima syndrome.